Zhengguangmycin A6 Uses, Dosage, Side Effects and more
Zhengguangmycin A6 (also known as boanmycin) has been used in trials studying the treatment of Squamous Cell Lung Cancer. It was developed in China as an antineoplastic antibiotic. This drug participated in clinical trials for the treatment of Squamous Cell Lung Cancer. It was shown that besides the antitumor effect, Zhengguangmycin A6 had the ability to alter the tumor microenvironment and could contribute toward lung cancer relapse and metastasis on long-term treatment. The development of this drug, apparently, was discontinued.
| Trade Name | Zhengguangmycin A6 |
| Generic | Bleomycin A6 |
| Bleomycin A6 Other Names | Boanmycin, Pingyangmycin A6, Zhengguangmycin A6 |
| Type | |
| Formula | C60H96N20O21S2 |
| Weight | Average: 1497.67 Monoisotopic: 1496.650032539 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
